Healthcare
Live Price
Offline$21.64
+0.00% today
Window Change
+126.83%
Window
Jun 23, 2025 → Feb 13, 2026
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 164 bars · Jun 23, 2025 → Feb 13, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Avadel Pharmaceuticals plc (AVDL) is a Healthcare stock with a market cap of $2.12B. The stock last traded around $21.64 and up 126.8% across the available one-year price window (Jun 23, 2025 → Feb 13, 2026). Baseline metrics include revenue growth of +504.8%, EPS growth of +74.5%, a dividend yield of 0.0%. What stands out right now is revenue +504.8%, EPS +74.5%, free cash flow +63.5% with operating margin 1.8% and ROIC 0.3%. Valuation already assumes a fairly strong business story at price/sales 8.5. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines AVDL price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
AVDL
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
AVDL Max Drawdown
-13.74%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for AVDL and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.